Helix BioPharma Corporation
4 clinical trials · Sponsor
◉ Watch Helix BioPharma Corporation
| Record | Firm | Date |
|---|---|---|
| L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer (NCT04203641) | Helix BioPharma Corporation | 2019-12-11 |
| A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma (NCT03891173) | Helix BioPharma Corporation | 2019-02-19 |
Track Helix BioPharma Corporation automatically
Every clearance here is in the API, with alerts when new ones post.